Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M414154200 on January 19, 2005

J. Biol. Chem., Vol. 280, Issue 12, 11790-11797, March 25, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/12/11790    most recent
M414154200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rangwala, R.
Right arrow Articles by Sherman, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rangwala, R.
Right arrow Articles by Sherman, L. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Erbin Regulates Mitogen-activated Protein (MAP) Kinase Activation and MAP Kinase-dependent Interactions between Merlin and Adherens Junction Protein Complexes in Schwann Cells*

Reshma Rangwala{ddagger}§, Fatima Banine{ddagger}, Jean-Paul Borg¶, and Larry S. Sherman{ddagger}||

From the {ddagger}Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon 97006 and the Molecular Pharmacology, Institut de Cancérologie de Marseille, UM599, INSERM and Institut Paoli-Calmettes, Marseille 13009, France

Biallelic mutations in the neurofibromatosis 2 (NF2) gene are linked to schwannoma and meningioma tumorigenesis. Cells with NF2 mutations exhibit elevated levels of phosphorylated extracellular signal-regulated kinase (ERK) and aberrant cell-cell and cell-matrix contacts. The NF2 gene product, merlin, associates with adherens junction protein complexes, suggesting that part of its function as a tumor suppressor involves regulating cell junctions. Here, we find that a novel PDZ protein, called erbin, binds directly to the merlin-binding partner, EBP0, and regulates adherens junction dissociation through a MAP kinase-dependent mechanism. Reducing erbin expression using a targeted siRNA in primary cultures of Schwann cells results in altered cell-cell interactions, disruption of E-cadherin adherens junctions, increased cell proliferation, and elevated levels of phosphorylated ERK, all phenotypes observed in cells that lack merlin. Reduction of erbin expression also results in the dissociation of merlin from adherens junction proteins and an increase in the levels of phosphorylated merlin. These phenotypes can be rescued if cells with reduced levels of erbin are treated with a pharmacological inhibitor of ERK kinase. Collectively, these data indicate that erbin regulates MAP kinase activation in Schwann cells and suggest that erbin links merlin to both adherens junction protein complexes and the MAP kinase signaling pathway.


Received for publication, December 16, 2004 , and in revised form, January 18, 2005.

* This work was supported by Grants NS39550 and RR00163 from the National Institutes of Health and by a University of Cincinnati Functional Genomics Fellowship. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Current address: University of Cincinnati College of Medicine, Physician Scientist Training Program and Graduate Program in Neuroscience, Cincinnati, OH 45267.

|| To whom correspondence should be addressed: Division of Neuroscience, Oregon National Primate Research Center, 505 NW 185th Ave., Beaverton, OR 97006. Tel.: 503-690-5217; Fax: 503-690-5384; E-mail: shermanl{at}ohsu.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Tao, P. Dai, Y. Liu, S. Marchetto, W.-C. Xiong, J.-P. Borg, and L. Mei
Erbin regulates NRG1 signaling and myelination
PNAS, June 9, 2009; 106(23): 9477 - 9482.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. Denisenko, C. Cifuentes-Diaz, T. Irinopoulou, M. Carnaud, E. Benoit, M. Niwa-Kawakita, F. Chareyre, M. Giovannini, J.-A. Girault, and L. Goutebroze
Tumor Suppressor Schwannomin/Merlin Is Critical for the Organization of Schwann Cell Contacts in Peripheral Nerves
J. Neurosci., October 15, 2008; 28(42): 10472 - 10481.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Arikkath, I. Israely, Y. Tao, L. Mei, X. Liu, and L. F. Reichardt
Erbin Controls Dendritic Morphogenesis by Regulating Localization of {delta}-Catenin
J. Neurosci., July 9, 2008; 28(28): 7047 - 7056.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
I. Izawa, M. Nishizawa, Y. Hayashi, and M. Inagaki
Palmitoylation of ERBIN is required for its plasma membrane localization.
Genes Cells, July 1, 2008; 13(7): 691 - 701.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. O. Hanemann
Magic but treatable? Tumours due to loss of Merlin
Brain, March 1, 2008; 131(3): 606 - 615.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
D. R. Scoles, W. H. Yong, Y. Qin, K. Wawrowsky, and S. M. Pulst
Schwannomin inhibits tumorigenesis through direct interaction with the eukaryotic initiation factor subunit c (eIF3c)
Hum. Mol. Genet., April 1, 2006; 15(7): 1059 - 1070.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Dai, W. C. Xiong, and L. Mei
Erbin Inhibits RAF Activation by Disrupting the Sur-8-Ras-Raf Complex
J. Biol. Chem., January 13, 2006; 281(2): 927 - 933.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. McDonald, F. F. Chen, V. Ollendorff, Y. Ogura, S. Marchetto, P. Lecine, J.-P. Borg, and G. Nunez
A Role for Erbin in the Regulation of Nod2-dependent NF-{kappa}B Signaling
J. Biol. Chem., December 2, 2005; 280(48): 40301 - 40309.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. I. McClatchey and M. Giovannini
Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin
Genes & Dev., October 1, 2005; 19(19): 2265 - 2277.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement